Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
THB 4.94
Key Takeaways
Risk factor
Very poor trading liquidity
Data is available to registered users only
Data is available to registered users only
Profitability factor
Undervalued vs peers
Data is available to registered users only
Data is available to registered users only
About
Ratchaphruek Hospital Public Company Limited engages in the hospital business under the Ratchaphruek Hospital name in Thailand. The company provides medical services in the field of internal medicine, such as dermatology, neurology, hematology, pulmonary, rheumatology, gastroenterology, nephrology, diabetes and endocrine, and cardiology; general, urological, and colorectal surgeries; and pediatrics, orthopedics, otorhinolaryngology, ophthalmology, obstetrics and gynecology,...
Company Valuation
Considering past and projected metrics, the stock is 'cheaper' than its peers. Specifically, the stock is fairly valued on P/E, undervalued on EV/EBITDA, underpriced on P
Data is available to registered users only
Buy
Sell